E-Based Technology to Provide Decision Aid on Breast Reconstruction for Women With Breast Cance

Overview

Using decision aids has been demonstrated to support women to make treatment decision effectively. However, these studies focused on the decision of receiving breast conservative surgery or mastectomy, had short term follow-ups on decision satisfaction.The aims of this study were: Evaluate the effect of E-based & personalized breast reconstruction surgery decision aid on women's decision satisfaction and mental health.

Full Title of Study: “The Effect of E-Based Technology to Provide Personalized Decision Aid on Breast Reconstruction for Women With Breast Cancer”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Supportive Care
    • Masking: Triple (Care Provider, Investigator, Outcomes Assessor)
  • Study Primary Completion Date: July 25, 2019

Detailed Description

Randomized controlled trial will be used to examine the effect of E-based & personalized breast reconstruction surgery decision aid on decision satisfaction, body image, anxiety and depression. Participants will be randomly assigned into either experimental or control groups with 88 women in each group. After completing the questionnaires at baseline, participants in the experimental group will be asked to receive a E-based & personalized breast reconstruction surgery decision aid at clinic. Control group will only receive pamphlet and usual care. All participants will be followed up 1 week after consultation, and 1 month, 8 month and 12 month after surgery.

Interventions

  • Other: E-based & personalized breast reconstruction surgery decision aid
    • This decision aid contains information regarding surgical options, including breast reconstruction and mastectomy, such as the advantages and disadvantages, the complication probabilities of each option, a value clarification exercise for the patient’s self-evaluation, and a summary of the participant’s decision-making process.
  • Other: Usual care
    • A pamphlet introduce the introduction of types of surgery

Arms, Groups and Cohorts

  • Experimental: Application (APP) group
    • After completing the questionnaires at baseline, participants in the experimental group will be asked to receive a pamphlet and an E-based & personalized breast reconstruction surgery decision aid at clinic.
  • Other: Usual care group
    • After completing the questionnaires at baseline, participants in the control group will only receive a pamphlet as usual care

Clinical Trial Outcome Measures

Primary Measures

  • Body image
    • Time Frame: Pre-surgery, 1 month, 8 month, 12 month post surgery
    • The Body Image Scale (BIS) has ten items rated on a four-point Likert scale (0 [not at all] to 3 [very much]), with total scores ranging from 0 to 30. Higher scores indicate greater BI distress.
  • Decision Regret
    • Time Frame: 1 month, 8 month, 12 month post surgery
    • Decision Regret Scale (DRS) accesses “distress or remorse after a surgery decision”. This instrument contains 5 items. The items were summed, divided by 5, and multiplied by 25. Higher scores indicate greater decision regret.
  • Decision conflict
    • Time Frame: Pre-surgery, 1 week after intervention
    • Decision Conflict Scale (DCS) accesses the perception of uncertainty in information, values or support for surgery options. This instrument contains 16 items and was developed by O’Connor. The items were summed, divided by 16, and multiplied by 25. Higher scores indicate greater decision conflict.

Secondary Measures

  • Anxiety
    • Time Frame: Pre-surgery, 1 month, 8 month, 12 month post surgery
    • The Hospital Anxiety and Depression Scale (HADS) assesses symptoms of anxiety and depression. The HADS includes 14 items, of which 7 measure anxiety, and 7 measure depression. All items are scored using a 0-3 point scale, with higher scores indicating more depressive symptoms. Cut-off scores are used to categorize anxiety and depressive symptoms, with values of over 8 indicating possible anxiety and depression, and 11 or above indicating probable anxiety.
  • Depression
    • Time Frame: Pre-surgery, 1 month, 8 month, 12 month post surgery
    • The Hospital Anxiety and Depression Scale (HADS) assesses symptoms of anxiety and depression. The HADS includes 14 items, of which 7 measure anxiety, and 7 measure depression. All items are scored using a 0-3 point scale, with higher scores indicating more depressive symptoms. Cut-off scores are used to categorize anxiety and depressive symptoms, with values of over 8 indicating possible anxiety and depression, and 11 or above indicating probable depression.
  • Involvement in the Breast Reconstruction (BR) decision-making process scale
    • Time Frame: 1 week after intervention
    • Involvement in the BR decision-making process was divided into two subscales, one accesses the perception of medical information about surgery obtained with 6 items and the other assesses the perception of partners’ involvement in the BR decision-making process with 7 items. The scale used a five-point Likert scale (1 [strongly disagree] to 5 [strongly agree]); the higher the score, the greater the amount of information the participants believed they had obtained and the greater the participants perceived their partner’s involvement in the BR decision-making process.

Participating in This Clinical Trial

Inclusion Criteria

  • age of at least 20 years or under 20 years but married – females newly diagnosed with breast cancer who are candidates for mastectomy – ability to read and speak Taiwanese or Mandarin Exclusion Criteria:

  • Women with cancer recurrence – poor cognitive function – diagnosed with psychiatric disease

Gender Eligibility: Female

Minimum Age: 20 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • National Cheng-Kung University Hospital
  • Collaborator
    • National Cheng Kung University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Su-Ying Fang, Associate Professor – National Cheng Kung University
  • Overall Official(s)
    • Su-Ying Fang, PhD, Principal Investigator, National Cheng Kung University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.